Clinical Trial NCT05630001

Back to all clinical trials

Trial

Novartis – CLNP023C12303 (NCT05630001)

Clinical trial ID

NCT05630001

Drug name

Iptacopan

Company:

Novartis

Drug trade name

Fabhalta®

Clinicaltrials.gov

Learn more

Phase of study

3

Current status

Recruiting

Start

04/2023

Substance

Low molecular compound

Research question

Patients on stable eculizumab or ravulizumab treatment and Hb≥10 g/dl

Delivery method of drug

Oral

Frequency

2 x daily

Clinical trial locations

tbd